maprotiline has been researched along with amoxapine in 35 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 23 (65.71) | 18.7374 |
| 1990's | 4 (11.43) | 18.2507 |
| 2000's | 2 (5.71) | 29.6817 |
| 2010's | 5 (14.29) | 24.3611 |
| 2020's | 1 (2.86) | 2.80 |
| Authors | Studies |
|---|---|
| Medina-Hernández, MJ; Quiñones-Torrelo, C; Sagrado, S; Villanueva-Camañas, RM | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Ahman, M; Holmén, AG; Wan, H | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Cardoso, FC; Duggan, PJ; Kuiper, MJ; Lewis, RJ; Schmit, M; Tuck, KL | 1 |
| Iri, H; Kanba, S; Kubo, H; Matsumoto, K; Yagi, G; Yuki, H | 1 |
| Brown, TM; Evans, DL; Golden, RN; Miller, H | 1 |
| Hayes, PE; Kristoff, CA | 1 |
| Aono, T; Koizumi, K; Tanizawa, O | 1 |
| Kulig, K | 1 |
| Gorman, RL; Klein-Schwartz, W; Oderda, GM; Wedin, GP | 1 |
| Fabre, LF | 1 |
| Blaine, JD; Levine, J; Prien, RF | 1 |
| Mattes, JA | 1 |
| Thompson, TL | 1 |
| Golden, RN; Potter, WZ; Rudorfer, MV | 1 |
| Dominguez, RA | 1 |
| Kane, JM; Lieberman, J | 1 |
| Gold, MS; Lydiard, RB; Pottash, AL | 1 |
| Glassman, AH | 1 |
| Robinson, DS | 1 |
| Itoh, M; Nakao, H; Notomi, A; Yufu, N | 1 |
| Gever, LN | 1 |
| Beierle, FA; Hubbard, RW | 1 |
| Ketchum, C; Robinson, CA; Scott, JW | 1 |
| Waugh, SW; Wong, SH | 1 |
| Hollister, LE | 1 |
| Settle, EC | 1 |
| Glassman, AH; Preud'homme, XA | 1 |
| Kodama, Y; Nomura, S; Shimizu, K; Watanabe, M | 1 |
| Oteri, G; Pisani, F; Spina, E | 1 |
9 review(s) available for maprotiline and amoxapine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
The new antidepressants.
Topics: Alprazolam; Amoxapine; Antidepressive Agents; Fluoxetine; Maprotiline; Nomifensine; Seizures; Trazodone | 1988 |
Adverse reactions to five new antidepressants.
Topics: Acute Kidney Injury; Amoxapine; Animals; Antidepressive Agents; Bupropion; Cardiovascular Diseases; Dopamine Antagonists; Humans; Male; Maprotiline; Nomifensine; Priapism; Propiophenones; Seizures; Trazodone | 1986 |
Management of poisoning associated with "newer" antidepressant agents.
Topics: Amoxapine; Antidepressive Agents; Antidepressive Agents, Tricyclic; Emergencies; Humans; Maprotiline; Structure-Activity Relationship; Trazodone | 1986 |
Second-generation antidepressants.
Topics: Alprazolam; Amoxapine; Antidepressive Agents; Benzodiazepines; Bupropion; Citalopram; Clinical Trials as Topic; Dopamine; Double-Blind Method; Humans; Maprotiline; Nomifensine; Norepinephrine; Propiophenones; Propylamines; Seizures; Serotonin; Trazodone; Zimeldine | 1984 |
The efficacy of amoxapine, maprotiline, and trazodone in comparison to imipramine and amitriptyline: a review of the literature.
Topics: Amitriptyline; Amoxapine; Anthracenes; Clinical Trials as Topic; Depression; Dibenzoxazepines; Humans; Imipramine; Maprotiline; Piperazines; Time Factors; Trazodone | 1984 |
'Second generation' antidepressant drugs.
Topics: Amoxapine; Antidepressive Agents; Antidepressive Agents, Tricyclic; Clomipramine; Humans; Maprotiline; Mianserin; Nomifensine; Trazodone; Viloxazine | 1981 |
Review of the cardiovascular effects of heterocyclic antidepressants.
Topics: Amoxapine; Antidepressive Agents; Antidepressive Agents, Tricyclic; Arrhythmias, Cardiac; Bupropion; Cardiovascular Diseases; Cardiovascular Physiological Phenomena; Cardiovascular System; Depressive Disorder; Heart; Humans; Hypotension, Orthostatic; Maprotiline; Selective Serotonin Reuptake Inhibitors; Trazodone | 1993 |
Antidepressant drugs and seizure susceptibility: from in vitro data to clinical practice.
Topics: Amoxapine; Animals; Antidepressive Agents; Comorbidity; Contraindications; Depressive Disorder; Dose-Response Relationship, Drug; Epilepsy; Humans; In Vitro Techniques; Incidence; Maprotiline; Risk Factors | 1999 |
5 trial(s) available for maprotiline and amoxapine
| Article | Year |
|---|---|
Treatment of depression in outpatients: a controlled comparison of the onset of action of amoxapine and maprotiline.
Topics: Adult; Ambulatory Care; Amoxapine; Anthracenes; Clinical Trials as Topic; Depressive Disorder; Dibenzoxazepines; Double-Blind Method; Female; Humans; Male; Maprotiline; Patient Dropouts; Personality Inventory; Psychiatric Status Rating Scales; Time Factors | 1985 |
Second-generation antidepressants.
Topics: Alprazolam; Amoxapine; Antidepressive Agents; Benzodiazepines; Bupropion; Citalopram; Clinical Trials as Topic; Dopamine; Double-Blind Method; Humans; Maprotiline; Nomifensine; Norepinephrine; Propiophenones; Propylamines; Seizures; Serotonin; Trazodone; Zimeldine | 1984 |
Evaluating the effectiveness of the new antidepressants.
Topics: Amoxapine; Antidepressive Agents; Clinical Trials as Topic; Depressive Disorder; Humans; Maprotiline; Trazodone; Trimipramine | 1983 |
The efficacy of amoxapine, maprotiline, and trazodone in comparison to imipramine and amitriptyline: a review of the literature.
Topics: Amitriptyline; Amoxapine; Anthracenes; Clinical Trials as Topic; Depression; Dibenzoxazepines; Humans; Imipramine; Maprotiline; Piperazines; Time Factors; Trazodone | 1984 |
Speed of onset of action of the newer antidepressants.
Topics: Amitriptyline; Amoxapine; Antidepressive Agents; Clinical Trials as Topic; Depression; Depressive Disorder; Double-Blind Method; Humans; Imipramine; Maprotiline; Time Factors; Trazodone | 1984 |
23 other study(ies) available for maprotiline and amoxapine
| Article | Year |
|---|---|
Development of predictive retention-activity relationship models of tricyclic antidepressants by micellar liquid chromatography.
Topics: Adenylyl Cyclase Inhibitors; Adrenergic alpha-Antagonists; Animals; Antidepressive Agents, Tricyclic; Chromatography, Liquid; Enzyme Inhibitors; Histamine H1 Antagonists; Micelles; Models, Biological; Norepinephrine; Rats; Receptors, Adrenergic, alpha-1; Selective Serotonin Reuptake Inhibitors; Serotonin; Structure-Activity Relationship | 1999 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Relationship between brain tissue partitioning and microemulsion retention factors of CNS drugs.
Topics: Brain; Central Nervous System; Chromatography, Liquid; Emulsions; Mass Spectrometry | 2009 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Inhibition of N-type calcium ion channels by tricyclic antidepressants - experimental and theoretical justification for their use for neuropathic pain.
Topics: | 2022 |
Automated determination of drugs in serum by column-switching high-performance liquid chromatography. IV. Separation of tricyclic and tetracyclic antidepressants and their metabolites.
Topics: Amitriptyline; Amoxapine; Antidepressive Agents; Antidepressive Agents, Tricyclic; Autoanalysis; Chromatography, High Pressure Liquid; Clomipramine; Humans; Hydrogen-Ion Concentration; Maprotiline; Nortriptyline; Quality Control; Regression Analysis | 1989 |
The acute effects of antidepressants, maprotiline and amoxapine on serum prolactin and gonadotropin levels in normal women.
Topics: Adult; Amoxapine; Anthracenes; Dibenzoxazepines; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Maprotiline; Prolactin | 1986 |
Relative toxicity of cyclic antidepressants.
Topics: Adolescent; Adult; Aged; Amoxapine; Anthracenes; Antidepressive Agents, Tricyclic; Arrhythmias, Cardiac; Central Nervous System Diseases; Child; Child, Preschool; Coma; Dibenzoxazepines; Female; Humans; Male; Maprotiline; Maryland; Middle Aged; Poison Control Centers; Retrospective Studies; Seizures; Tachycardia; Trazodone | 1986 |
Antidepressant drug therapy: the role of the new antidepressants.
Topics: Amoxapine; Antidepressive Agents; Bupropion; Cardiovascular Diseases; Depressive Disorder; Drug Evaluation; Humans; Legislation, Drug; Maprotiline; Propiophenones; Trazodone; United States | 1985 |
Side effects of the new antidepressants.
Topics: Amoxapine; Anthracenes; Antidepressive Agents; Dibenzoxazepines; Humans; Maprotiline; Trazodone | 1986 |
Update on some of the older and newer antidepressants.
Topics: Aged; Amoxapine; Antidepressive Agents; Arrhythmias, Cardiac; Humans; Maprotiline; Parasympathetic Nervous System; Sleep Stages; Trazodone | 1985 |
The newer antidepressant drugs and their cardiovascular effects.
Topics: Amoxapine; Antidepressive Agents; Bupropion; Cardiovascular System; Electrocardiography; Humans; Hypotension, Orthostatic; Maprotiline; Myocardial Contraction; Propiophenones; Trazodone | 1984 |
Adverse reactions, toxicities, and drug interactions of newer antidepressants: anticholinergic, sedative, and other side effects.
Topics: Amoxapine; Antidepressive Agents; Bupropion; Drug Interactions; Humans; Hypnotics and Sedatives; Maprotiline; Parasympatholytics; Propiophenones; Trazodone | 1984 |
Simultaneous measurement of various antidepressants in the plasma of depressed patients by high performance liquid chromatography.
Topics: Adult; Amitriptyline; Amoxapine; Antidepressive Agents; Chromatography, High Pressure Liquid; Clomipramine; Depressive Disorder; Desipramine; Dose-Response Relationship, Drug; Female; Humans; Imipramine; Male; Maprotiline; Middle Aged; Nortriptyline | 1984 |
Three new antidepressants amoxapine, maprotiline, and trazodone.
Topics: Amoxapine; Antidepressive Agents; Depression; Humans; Maprotiline; Trazodone | 1983 |
Liquid chromatographic separation of antidepressant drugs: II. Amoxapine and maprotiline.
Topics: Amoxapine; Anthracenes; Biotransformation; Chromatography, High Pressure Liquid; Dibenzoxazepines; Humans; Maprotiline | 1983 |
Analysis of amoxapine, 8-hydroxyamoxapine, and maprotiline by high-pressure liquid chromatography.
Topics: Amoxapine; Anthracenes; Chromatography, High Pressure Liquid; Dibenzoxazepines; Half-Life; Humans; Maprotiline | 1983 |
Determination of the antidepressants maprotiline and amoxapine, and their metabolites, in plasma by liquid chromatography.
Topics: Amoxapine; Anthracenes; Antidepressive Agents; Chromatography, Liquid; Dibenzoxazepines; Humans; Maprotiline | 1983 |
Recently introduced antidepressants: their place in clinical practice.
Topics: Amoxapine; Antidepressive Agents; Bundle of His; Chemical Phenomena; Chemistry; Depressive Disorder; Electrocardiography; Erythema; Heart Rate; Humans; Maprotiline; Trazodone; Tremor; Trimipramine | 1982 |
[A case of allergic cross reaction between tricyclic antidepressants and maprotiline].
Topics: Aged; Amoxapine; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cross Reactions; Depression; Drug Eruptions; Female; Humans; Lofepramine; Maprotiline | 1998 |